Hemostatic efficacy of latest-generation fibrin sealant after hepatic resection: a randomized controlled clinical study

This randomized, controlled, single-blinded multicenter study evaluated the efficacy of latest-generation fibrin sealant containing synthetic aprotinin as fibrinolysis inhibitor as supportive treatment for hemostasis after elective partial hepatectomy.

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Bektaş, Hüseyin (VerfasserIn) , Nadalin, Silvio (VerfasserIn) , Szabo, Ildiko (VerfasserIn) , Ploder, Bettina (VerfasserIn) , Sharkhawy, Marlies (VerfasserIn) , Schmidt, Jan (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 19 July 2014
In: Langenbeck's archives of surgery
Year: 2014, Jahrgang: 399, Heft: 7, Pages: 837-847
ISSN:1435-2451
DOI:10.1007/s00423-014-1227-1
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1007/s00423-014-1227-1
Volltext
Verfasserangaben:Hüseyin Bektas, Silvio Nadalin, Ildiko Szabo, Bettina Ploder, Marlies Sharkhawy, Jan Schmidt
Beschreibung
Zusammenfassung:This randomized, controlled, single-blinded multicenter study evaluated the efficacy of latest-generation fibrin sealant containing synthetic aprotinin as fibrinolysis inhibitor as supportive treatment for hemostasis after elective partial hepatectomy.
Beschreibung:Gesehen am 09.07.2020
Beschreibung:Online Resource
ISSN:1435-2451
DOI:10.1007/s00423-014-1227-1